Disruption of Healthcare: Pathology Leadership and Innovation
Sydney, 16 November 2016
Date: 16 November 2016
Venue: Aerial UTS Function Centre
Cost: Early Bird (to 10/10/16): $480 Non-Member; $400 Member**
Post Early Bird: $620 Non-Member; $495 Member**
PLATINUM SPONSOR - SOLD OUT
$5,500 incl. GST
x 4 options
$2,750 incl. GST
x 6 Options
** Member discounts only apply to AIMS/AACB/IVD Australia Members. If you need help with registration, please contact IVD Australia on 0407 072 151 or via email
The Economic Value of Pathology: Achieving Better Health, and a Better Use of Health Resources
On Tuesday April 12, Pathology Awareness Australia launched an exciting new report at a pathology laboratory in central Sydney as part of our ongoing work to build understanding of pathology in the community.
Written by the Centre for International Economics, it is the first report in Australia to take a detailed look at the financial savings and broad benefits that pathology provides to the health system and patients. Focusing on the examples of diabetes, heart disease and bowel cancer, it highlights the central role of pathology in the prevention, diagnosis and treatment of disease.
To find out more about the report's findings and to read it in full click here
Go to our Members Home Page
IVD Australia is driven by our strategic plan and we have captured two key strategies that will help to ‘future-proof’ the IVD Industry in Australia – Driving Industry Value, and Recognition & Advocacy.
All our activities are focused on member-value; ensuring that government understands, and acts upon, the value of the Australian IVD Industry; and making sure industry’s voice is heard and respected.
IVD Australia Open Consultations
- Standards Australia - Oral Fluids Testing, Vendor Credentialling, Biological Evaluation
- IVD Australia - Vendor Credentialing
Visit the Open Consultations Page for more information.
Visit the Submissions Page to view our recent submissions.
Read the latest IVD Australia Media Release
IVD Australia often receives requests for assistance or sourcing products from industry. Members can click here to see these opportunities (log in required).
IVD Transition - Update
On 30 June 2015 the transition period for all commercial IVD medical devices ceased.
Sponsors are reminded that previous Listings or Registrations representing the transitioned IVD should be removed from the ARTG. Further information can be found on the TGA website.
TGA has also confirmed that commercial sponsors of IVDs will not be required to pay annual charges until October 2017. This will provide a significant benefit for the sector, saving an estimated $5-6 million in annual charges over the next 3 years.